ViaGen Pets (Texas, 2015-)
firmBiotech & Transhumanism
For about $50,000, a Texas company will clone your dead pet, and it's already made a thousand copies.
Who they are
ViaGen Pets, a Texas commercial pet-cloning firm operating since 2015.
What they do
The engine reads it as an industrialized version of something the public still thinks is fringe.
How it works
The successor to an earlier cloning company, it has produced over 600 cloned dogs and 400 cloned cats by 2024, holds about 25% of the global pet-cloning market at roughly $50,000 per dog, and operates entirely outside Western academic ethics rules as a purely commercial veterinary business.
Why it matters
It matters as a case where public perception (fringe novelty) lags far behind reality (an actual production line), and it ties genetic replication to the money and mortality-anxiety of the wealthy.
The engine's record — word for word
Successor to Genetic Savings & Clone (founded 1997, dissolved 2006). Re-launched commercial pet cloning 2015. 600+ cloned dogs + 400+ cloned cats by 2024. Commands ~25% global pet-cloning market share. Per-dog cost ~$50,000. Operates entirely outside Western academic ethical moratoria — pure commercial-veterinary jurisdiction. Engine framing: Substrate-vs-Announcement instance — public perception treats pet cloning as fringe, market reality is industrialized production line for elite genetic replication. Cap-table-adjacent to Longevity Industrial Complex operator-class capital (mortality-anxiety conversion mechanism applied to companion-animal layer).
Follow the trail
Walk this on the live map →